See more : Pacific Horizon Investment Trust PLC (PHI.L) Income Statement Analysis – Financial Results
Complete financial analysis of Allied Corp. (ALID) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Allied Corp., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- PT Industri Jamu dan Farmasi Sido Muncul Tbk (SIDO.JK) Income Statement Analysis – Financial Results
- ABG Sundal Collier Holding ASA (0IZM.L) Income Statement Analysis – Financial Results
- Hauman Technologies Corp. (6218.TWO) Income Statement Analysis – Financial Results
- Envestnet, Inc. (ENV) Income Statement Analysis – Financial Results
- Xinxiang Chemical Fiber Co., Ltd. (000949.SZ) Income Statement Analysis – Financial Results
Allied Corp. (ALID)
About Allied Corp.
Allied Corp., a medical cannabis production company, engages in the research, development, and production of cannabinoid health solutions in the United States. It offers hemp-derived natural health products, including Liberty, a hemp-derived cannabidiol (CBD) tincture; Tactical Hydration, a CBD infused electrolyte replacement drink; FIZZ Tablets for adding in a water bottle; Battle Balm, a CBD roll on activity rub for aches and pains; and Quick Hit, a CBD gummy under the Tactical Relief brand. The company also provides Hydrosport CBD Drink, a CBD infused electrolyte replacement drink with sodium citrate electrolyte replacement; Hydrosport Tincture, a CBD tincture fortified with specific terpene profile; FIZZ Tablets for adding to a water bottle; Sport Rub, a CBD post-activity rub for aches and pains; and Quick Hit, a CBD gummy with vitamin B12 under the Equilibrium Bio brand. In addition, it offers Skin Structure, a facial formula topically applied to enhance skin's radiance and youthfulness; Eye Recover that helps the eye skin ward off free radicals, as well as helping to protect against sun damage; Glossy Lip Recover, which moisturizes and nourishes lips; Skin Designer that stimulates cell regeneration while minimizing age spots; Vitamin Absolute, a moisturizing facial oil; and Absolute Recover, a formulation that allows the infused bioactive compounds to be delivered directly to the desired areas of inflammation, pain, and other skin ailments under the MaXXa brand. In addition, it is developing ALID 10 and ALID 11, a pharma product, which is in Phase I clinical trial for treating post-traumatic stress disorder. The company was incorporated in 2013 and is headquartered in Kelowna, Canada.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 72.10K | 165.60K | 12.52K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9.00K | 0.00 |
Cost of Revenue | 1.53M | 91.48K | 637.99K | 90.54K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | -1.46M | 74.12K | -625.47K | -90.54K | 0.00 | 0.00 | 0.00 | 0.00 | 9.00K | 0.00 |
Gross Profit Ratio | -2,027.53% | 44.76% | -4,996.60% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 0.00% |
Research & Development | 0.00 | 12.06K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 5.22M | 14.25M | 5.81M | 2.82M | 23.11K | 19.25K | 20.25K | 2.06K | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 5.22M | 14.25M | 5.81M | 2.82M | 23.11K | 19.25K | 20.25K | 2.06K | 0.00 | 0.00 |
Other Expenses | 8.36M | 126.26K | 557.88K | 466.87K | 0.00 | 0.00 | 0.00 | 0.00 | -16.53K | 0.00 |
Operating Expenses | 5.37M | 14.38M | 6.37M | 3.29M | 23.11K | 19.25K | 20.25K | 2.06K | -16.53K | 0.00 |
Cost & Expenses | 6.90M | 14.48M | 7.01M | 3.29M | 23.11K | 19.25K | 20.25K | 2.06K | -16.53K | 0.00 |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 863.20K | 1.23M | 625.42K | 148.24K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 137.05K | 82.59K | 547.48K | 466.04K | 171.86K | 161.14K | 52.52K | 22.82K | 0.00 | 0.00 |
EBITDA | -6.69M | -14.23M | -7.05M | -3.04M | -23.11K | -19.25K | -20.25K | -2.06K | -7.53K | 0.00 |
EBITDA Ratio | -9,284.79% | -8,591.36% | -56,332.09% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -83.66% | 0.00% |
Operating Income | -10.26M | -14.31M | -7.60M | -3.51M | -23.11K | -19.25K | -20.25K | -2.06K | -7.53K | 0.00 |
Operating Income Ratio | -14,235.43% | -8,641.23% | -60,705.62% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -83.66% | 0.00% |
Total Other Income/Expenses | -2.98M | -1.23M | -3.89M | -3.10M | -23.11K | -19.25K | 0.00 | 0.00 | 0.00 | 0.00 |
Income Before Tax | -10.68M | -15.54M | -11.49M | -6.61M | -23.11K | -19.25K | -20.25K | -2.06K | -7.53K | 0.00 |
Income Before Tax Ratio | -14,807.58% | -9,383.59% | -91,749.85% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -83.66% | 0.00% |
Income Tax Expense | 863.20K | 1.23M | 673.94K | 154.77K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income | -10.68M | -16.77M | -12.16M | -6.76M | -23.11K | -19.25K | -20.25K | -2.06K | -7.53K | 0.00 |
Net Income Ratio | -14,807.58% | -10,128.99% | -97,133.62% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -83.66% | 0.00% |
EPS | -0.11 | -0.18 | -0.15 | -0.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPS Diluted | -0.11 | -0.18 | -0.15 | -0.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Weighted Avg Shares Out | 96.80M | 92.10M | 80.39M | 80.75M | 86.66M | 86.66M | 13.00M | 13.00M | 0.00 | 0.00 |
Weighted Avg Shares Out (Dil) | 96.80M | 92.10M | 80.39M | 80.75M | 86.66M | 86.66M | 13.00M | 13.00M | 0.00 | 0.00 |
Allied Corp. Announces Clearance From the Colombian Authorities to Export Cannabis Products Internationally
Allied Corp Announces Production Results Showcasing Low Cost Per Gram, High Yield and Large Cannabinoid Percentages Positioning the Company for International Stage
Allied Corp Secures US Footprint in Preparation for US Federal Legalization of Cannabis With Signing of Land Lease, Purchase of US License and Master Service Agreement
Allied Corp Increases Intellectual Property Protection by Filing Trademark for Pharma Product PSILONEX
Allied Corp. Receives ICA Approval for Psychoactive THC Strains
Allied Corp. Launches Strategic North American Public Relations and Marketing Campaign
Allied Corp Announces LOI to Purchase Nevada USA Cannabis License and Land Lease to Install the Allied US Facility
Allied Completes Acquisition of Pacific Sun Fungi: A Leader in the Psilocybin Space
Allied Wants To Conquer Psilocybin Space, Plans To Acquire Pacific Sun Fungi
Allied Moves to Become Leader in Psilocybin Space with Intent to Acquire Pacific Sun Fungi
Source: https://incomestatements.info
Category: Stock Reports